Subscribe for the newsletter
Sign in
Articles
Expert Interviews
Roundtable
Press Releases
Videos
The Road To Series
Market Research
Thought Leaders
More
Discovery
Small Molecules
Biologics
Advanced Therapies
Manufacturing
Supply Chain
Clinical Trials
Technologies
Financing
Osteoporosis
Sort By
Newest First
1 / 1
1 / 1
Drug Development
EVENITY™ (romosozumab-aqqg) Now Available In The United States For The Treatment Of Osteoporosis In Postmenopausal Women At High Risk For Fracture
Amgen
PR-M04-19-NI-054
Apr 17, 2019
FDA Approval
FDA Approves New Treatment for Osteoporosis in Postmenopausal Women at High Risk of Fracture
U.S. Food & Drug Administration
PR-M04-19-NI-041
Apr 12, 2019
